1. Home
  2. TMDX vs HUBG Comparison

TMDX vs HUBG Comparison

Compare TMDX & HUBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • HUBG
  • Stock Information
  • Founded
  • TMDX 1998
  • HUBG 1971
  • Country
  • TMDX United States
  • HUBG United States
  • Employees
  • TMDX N/A
  • HUBG N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HUBG Oil Refining/Marketing
  • Sector
  • TMDX Health Care
  • HUBG Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • HUBG Nasdaq
  • Market Cap
  • TMDX 2.3B
  • HUBG 2.0B
  • IPO Year
  • TMDX 2019
  • HUBG 1996
  • Fundamental
  • Price
  • TMDX $111.50
  • HUBG $33.23
  • Analyst Decision
  • TMDX Buy
  • HUBG Buy
  • Analyst Count
  • TMDX 10
  • HUBG 8
  • Target Price
  • TMDX $122.89
  • HUBG $46.27
  • AVG Volume (30 Days)
  • TMDX 1.2M
  • HUBG 597.3K
  • Earning Date
  • TMDX 05-08-2025
  • HUBG 05-08-2025
  • Dividend Yield
  • TMDX N/A
  • HUBG 1.51%
  • EPS Growth
  • TMDX N/A
  • HUBG N/A
  • EPS
  • TMDX 1.41
  • HUBG 1.70
  • Revenue
  • TMDX $488,227,000.00
  • HUBG $3,862,113,000.00
  • Revenue This Year
  • TMDX $25.33
  • HUBG $4.73
  • Revenue Next Year
  • TMDX $20.53
  • HUBG $7.07
  • P/E Ratio
  • TMDX $79.36
  • HUBG $19.48
  • Revenue Growth
  • TMDX 64.43
  • HUBG N/A
  • 52 Week Low
  • TMDX $55.00
  • HUBG $30.75
  • 52 Week High
  • TMDX $177.37
  • HUBG $53.21
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 78.52
  • HUBG 49.20
  • Support Level
  • TMDX $92.49
  • HUBG $30.75
  • Resistance Level
  • TMDX $95.71
  • HUBG $33.30
  • Average True Range (ATR)
  • TMDX 4.79
  • HUBG 1.17
  • MACD
  • TMDX 0.81
  • HUBG 0.32
  • Stochastic Oscillator
  • TMDX 71.36
  • HUBG 70.06

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About HUBG Hub Group Inc.

Hub Group ranks among the largest providers of rail intermodal service. Roughly 60% of consolidated revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset light truck brokerage operations, along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub is somewhat acquisitive in that it often makes tuck-in acquisitions which expand its brokerage, last-mile, and dedicated offerings.

Share on Social Networks: